<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02922660</url>
  </required_header>
  <id_info>
    <org_study_id>ZOCMZK-2016</org_study_id>
    <nct_id>NCT02922660</nct_id>
  </id_info>
  <brief_title>Comparison of Desflurane Anesthesia Versus TIVA-TCI in Patients Undergoing Ophthalmic Ambulatory Surgery</brief_title>
  <official_title>Comparison of Desflurane Balanced Anesthesia Versus TIVA-TCI (Total IntraVenous Anesthesia-Target Controlled Infusion) in Patients Undergoing Ophthalmic Ambulatory Surgery: A Single Center, Prospective, Randomized, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiaoliang Gan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single-center, randomized, prospective research which aims to investigate the
      advantages and disadvantages between desflurane balanced anesthesia and TIVA-TCI with
      propofol in ophthalmic ambulatory surgery, so that to evaluate a better anesthesia method in
      ophthalmic surgery through a large sample clinical study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Desflurane balanced anesthesia and TIVA-TCI(Total IntraVenous Anesthesia-Target Controlled
      Infusion) are commonly used in ophthalmic ambulatory surgery, however, there is no clear
      evidence to discriminate the advantages and disadvantages between them. This study is
      designed to evaluate a better anesthetic method in ophthalmic surgery through a clinical
      study. This is a single center, randomized, prospective study. 200 patients with American
      Society of Anesthesiologists'(ASA) physical status 1 to 2, aged 18 to 60, scheduled for
      elective strabismus ambulatory and in whom a LMA is indicated for anesthesia are recruited.
      Enrolled patients are randomly assigned into 2 groups: group TIVA (TIVA-TCI with propofol)
      and group Des (Desflurane).In group TIVA, anesthesia is maintained with propofol and
      remifentanil. Propofol is continuously administered via a target-controlled infusion (TCI)
      pump intraoperatively. In group Des, anesthesia is maintained with desflurane.All patients
      received anaesthesia depth monitoring with bispectral index (BIS). The dose of anesthetic is
      adjusted to maintained the BIS value within 40 to 60. At the end of the surgery, inhalant
      anesthetic or infused propofol and remifentanil are discontinued. LMA is removed when patient
      regains consciousness with spontaneous respiration. Patients are then transferred to the post
      anesthetic care unit (PACU) for postoperative follow-up. The primary outcome is awake time,
      the secondary outcomes include discharge time, the stay time in PACU, time of off-bed, Riker
      sedation agitation score (SAS), time of PADSS＞9, NRS score when leaving PACU, incidence of
      various complications (postoperative nausea and vomiting (PONV), emergence agitation, etc),
      as well as anesthesia cost. All patients are followed up by calling in one day after the
      surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Actual">January 2018</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Awake time</measure>
    <time_frame>From the ending time of anesthesia until the recovery time of patient's consciousness, assessed up to half an hour postoperatively.</time_frame>
    <description>&quot;Anesthesia ends&quot; means stop infusing or inhaling any anaesthetic.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Discharge time</measure>
    <time_frame>From the ending time of anesthesia until the time of extubation, assessed up to half an hour postoperatively.</time_frame>
    <description>The standards of extubation are tidal volume(VT) 6～8 ml/kg，respiratory rate(RR) 10～12 times per minute，end-tidal carbon dioxide (ETCO2) 35～45 mmHg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stay time in the postoperative care unit</measure>
    <time_frame>Measuring the stay time in postoperative care unit, assessed up to one hour postoperatively.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of recovery in 1 day postoperatively</measure>
    <time_frame>Start scaling when 1 day(24 hour) postoperatively.</time_frame>
    <description>It will use telephone follow-up for the patients enrolled.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidences in postoperative nausea and vomiting(PONV)</measure>
    <time_frame>Start scaling in 1 day(24 hour) postoperatively.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidences in postoperative agitation</measure>
    <time_frame>Start scaling in 1 day(24 hour) postoperatively.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anesthesia cost</measure>
    <time_frame>During the procedure of anesthesia.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative VAS pain score</measure>
    <time_frame>Start scaling in half an hour postoperatively when patient's consciousness returns.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">209</enrollment>
  <condition>Ophthalmic</condition>
  <condition>Surgery</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Group TIVA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>method of anesthesia is total intravenous anesthesia(TIVA) and maintenance with propofol Cp 2—4 μg/ml and remifentanil 2—4 ng/ml in target controlled infusion(TCI) during the procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Des</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>method of anesthesia is inhalation anesthesia and maintenance with desflurane ranged from 0.5~1.5 MAC during the procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>desflurane</intervention_name>
    <description>method of anesthesia maintenance with desflurane ranged from 0.5~1.5 MAC during the procedure</description>
    <arm_group_label>Group Des</arm_group_label>
    <other_name>Ethane,2--1,1,1,2-tetrafluoro</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>total intravenous anesthesia</intervention_name>
    <description>method of anesthesia in group TIVA is total intravenous anesthesia(TIVA) during the procedure</description>
    <arm_group_label>Group TIVA</arm_group_label>
    <other_name>TIVA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>inhalation anesthesia</intervention_name>
    <description>method of anesthesia in group DES is inhalation anesthesia with desflurane during the procedure</description>
    <arm_group_label>Group Des</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>using propofol as sedative during the procedure of anesthesia and maintaining with propofol Cp 2—4 μg/ml in TCI</description>
    <arm_group_label>Group TIVA</arm_group_label>
    <other_name>Disoprofol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>using remifentanil as analgesics during the procedure of anesthesia and maintaining with remifentanil 2—4 ng/ml in TCI</description>
    <arm_group_label>Group TIVA</arm_group_label>
    <other_name>Remifentanil Hydrochloride for Injection</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-60 years patients undergoing selective ophthalmic ambulatory surgery；

          -  ASA I and II

          -  duration of anesthesia at least 30min

          -  without apparent organ comorbidities

          -  sign the informed consent form

        Exclusion Criteria:

          -  equal or greater than ASA III

          -  has a history of dementia，psychiatric disorders or central nervous system diseases

          -  taking sedatives, antidepressant or glucocorticoid

          -  without family members

          -  has cardiac, respiratory，liver，kidney comorbidities

          -  uncontrolled hypertension（&gt;180/100mmHg）

          -  laryngeal mask fail to insert, and change to tracheal intubation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yizhi Liu</last_name>
    <role>Study Chair</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zhongshan ophthalmic center, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Aylin P, Williams S, Jarman B, Bottle A. Trends in day surgery rates. BMJ. 2005 Oct 8;331(7520):803.</citation>
    <PMID>16210281</PMID>
  </reference>
  <reference>
    <citation>Neel ST. Effect of Conversion to Immediate Sequential Cataract Surgery on Ambulatory Surgery Centers in the United States in the Cost-Analysis Model. JAMA Ophthalmol. 2015 Jul;133(7):856-7. doi: 10.1001/jamaophthalmol.2015.0941.</citation>
    <PMID>25906175</PMID>
  </reference>
  <reference>
    <citation>Chen CH, Yang YL, Chen WM, Shyr MH. Comparison of the anesthesia profiles between sevoflurane-nitrous oxide and propofol-nitrous oxide conveyed by laryngeal mask airway in patients undergoing ambulatory gynecological surgery. Acta Anaesthesiol Taiwan. 2006 Jun;44(2):101-7.</citation>
    <PMID>16845915</PMID>
  </reference>
  <reference>
    <citation>Kumar G, Stendall C, Mistry R, Gurusamy K, Walker D. A comparison of total intravenous anaesthesia using propofol with sevoflurane or desflurane in ambulatory surgery: systematic review and meta-analysis. Anaesthesia. 2014 Oct;69(10):1138-50. doi: 10.1111/anae.12713. Epub 2014 May 22. Review.</citation>
    <PMID>24847783</PMID>
  </reference>
  <reference>
    <citation>Coskun D, Celebi H, Karaca G, Karabiyik L. Remifentanil versus fentanyl compared in a target-controlled infusion of propofol anesthesia: quality of anesthesia and recovery profile. J Anesth. 2010 Jun;24(3):373-9. doi: 10.1007/s00540-010-0898-1. Epub 2010 Mar 13.</citation>
    <PMID>20229001</PMID>
  </reference>
  <reference>
    <citation>Majholm B, Bartholdy J, Clausen HV, Virkus RA, Engbæk J, Møller AM. Comparison between local anaesthesia with remifentanil and total intravenous anaesthesia for operative hysteroscopic procedures in day surgery. Br J Anaesth. 2012 Feb;108(2):245-53. doi: 10.1093/bja/aer337. Epub 2011 Nov 23.</citation>
    <PMID>22113931</PMID>
  </reference>
  <reference>
    <citation>Eikaas H, Raeder J. Total intravenous anaesthesia techniques for ambulatory surgery. Curr Opin Anaesthesiol. 2009 Dec;22(6):725-9. doi: 10.1097/ACO.0b013e3283310f6b. Review.</citation>
    <PMID>19680121</PMID>
  </reference>
  <reference>
    <citation>Yoo YC, Bai SJ, Lee KY, Shin S, Choi EK, Lee JW. Total intravenous anesthesia with propofol reduces postoperative nausea and vomiting in patients undergoing robot-assisted laparoscopic radical prostatectomy: a prospective randomized trial. Yonsei Med J. 2012 Nov 1;53(6):1197-202. doi: 10.3349/ymj.2012.53.6.1197.</citation>
    <PMID>23074122</PMID>
  </reference>
  <reference>
    <citation>Rinehardt EK, Sivarajan M. Costs and wastes in anesthesia care. Curr Opin Anaesthesiol. 2012 Apr;25(2):221-5. doi: 10.1097/ACO.0b013e32834f00ec. Review.</citation>
    <PMID>22157199</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 28, 2016</study_first_submitted>
  <study_first_submitted_qc>September 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2016</study_first_posted>
  <last_update_submitted>January 21, 2018</last_update_submitted>
  <last_update_submitted_qc>January 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Xiaoliang Gan</investigator_full_name>
    <investigator_title>associate chief physician</investigator_title>
  </responsible_party>
  <keyword>Ambulatory surgery</keyword>
  <keyword>Ophthalmic</keyword>
  <keyword>Inhalation anesthesia</keyword>
  <keyword>Desflurane</keyword>
  <keyword>Total intravenous anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

